APLMW vs BIIB: Which Stock is Better?

Side-by-side comparison of Apollomics Inc. and Biogen Inc in 2026

Comparison Updated:

APLMW

Apollomics Inc.

$0.01

BIIB

Biogen Inc

$180.54

Key Metrics Comparison

MetricAPLMWBIIBWinner
Market Cap$41.26M$26.26BBIIB
P/E RatioN/A20.38BIIB
EPS (TTM)$N/A$8.78BIIB
Revenue Growth0.0%-0.1%BIIB
Gross Margin0.0%78.9%BIIB

Analyze APLMW

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is APLMW or BIIB a better investment?

Comparing APLMW and BIIB: Apollomics Inc. has a market cap of $41.26M while Biogen Inc has $26.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between APLMW and BIIB?

APLMW (Apollomics Inc.) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: APLMW or BIIB?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: APLMW or BIIB?

APLMW has higher revenue growth at 0.0% vs -0.1% for BIIB.

Which company is more profitable: APLMW or BIIB?

Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 0.0% for APLMW.

Which is the larger company: APLMW or BIIB?

Biogen Inc (BIIB) is larger with a market cap of $26.26B compared to $41.26M for APLMW.

Should I buy APLMW or BIIB in 2026?

Both APLMW and BIIB have investment merit. APLMW trades at $0.01 while BIIB trades at $180.54. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between APLMW and BIIB stock?

Key differences: Market Cap ($41.26M vs $26.26B), P/E Ratio (N/A vs 20.4x), Revenue Growth (0.0% vs -0.1%), Gross Margin (0.0% vs 78.9%).

Popular Stock Comparisons